World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
73958
World Ranking
8721
National Ranking
4496

Overview

Joseph P. Costantino is affiliated with the University of Pittsburgh in the United States. Their research covers multiple fields within medicine, particularly focusing on oncology, molecular biology, and genetics, alongside contributions to nephrology and cardiology and cardiovascular medicine.

Their work predominantly addresses topics such as amyloidosis diagnosis and treatment, parathyroid disorders, breast cancer treatment studies, cancer treatment and pharmacology, prostate cancer research, neuroendocrine tumor advances, and cardiomyopathy and myosin studies.

Costantino has published in a variety of venues, with frequent contributions to the following journals:

  • European Heart Journal Supplements
  • Cancer Research
  • EP Europace
  • New England Journal of Medicine
  • Journal of Clinical Oncology

Notable papers include:

  • "Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer," 2021, New England Journal of Medicine
  • "Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor-Positive Breast Cancer," 2023, Journal of Clinical Oncology
  • "Abstract P5-06-02: Pathologic complete response (pCR) and prognosis following neoadjuvant chemotherapy plus anti-HER2 therapy of HER2-positive early breast cancer (EBC)," 2020, Cancer Research
  • "Landmark Proportional Subdistribution Hazards Models for Dynamic Prediction of Cumulative Incidence Functions," 2020, Journal of the Royal Statistical Society Series C (Applied Statistics)
  • "Abstract OT2-04-08: A randomized double-blind phase III clinical trial of neoadjuvant chemotherapy (NAC) with atezolizumab or placebo in patients (pts) with triple negative breast cancer (TNBC) followed by adjuvant atezolizumab or placebo: NSABP B-59/GBG 96-GeparDouze," 2020, Cancer Research

The scientist frequently collaborates with several researchers, including:

  • F Ballatore
  • Carmine Dario Vizza
  • Cristina Chimenti
  • Giulia Manguso
  • Maria Alfarano

Joseph P. Costantino's diverse scholarship reflects a multidisciplinary approach, combining clinical oncology research and molecular biology with statistical models and cardiovascular medicine. Their contributions span both clinical trial results and methodological advancements in prediction modeling.

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

    Victor G. Vogel;Joseph P. Costantino;D. Lawrence Wickerham;Walter M. Cronin

  • Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

    Patricia Cortazar;Lijun Zhang;Michael Untch;Keyur Mehta

  • Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

    Soonmyung Paik;Gong Tang;Steven Shak;Chungyeul Kim

  • Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

    David N. Krag;Stewart J. Anderson;Thomas B. Julian;Ann M. Brown

  • Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

    Victor G. Vogel;Joseph P. Costantino;D. Lawrence Wickerham;D. Lawrence Wickerham;Walter M. Cronin

  • A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive Tumors

    Fisher B;Costantino J;Redmond C;Poisson R

  • Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14

    Fisher B;Costantino Jp;Redmond Ck;Fisher Er

  • Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

    Bernard Fisher;Joseph P. Costantino;D. Lawrence Wickerham;Reena S. Cecchini

  • Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial

    David N Krag;Stewart J Anderson;Thomas B Julian;Ann M Brown

  • Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer

    B Fisher;J Costantino;C Redmond;E Fisher

  • Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-17

    B. Fisher;J. Dignam;N. Wolmark;E. Mamounas

  • Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer

    Andrew N.J. Tutt;Judy E. Garber;Bella Kaufman;Giuseppe Viale

  • Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors

    Bernard Fisher;James Dignam;John Bryant;Arthur DeCillis

  • Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer Incidence

    J P Costantino;M H Gail;D Pee;S Anderson

  • Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer

    Mitchell H. Gail;Joseph P. Costantino;John Bryant;Robert Croyle

  • Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Bernard Asselain;William Barlow;John Bartlett;Jonas Bergh

  • Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS

    Irene L. Wapnir;James J. Dignam;Bernard Fisher;Eleftherios P. Mamounas

  • Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

    Clifford A. Hudis;William E. Barlow;Joseph P. Costantino;Robert J. Gray

  • Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

    Mary Claire King;Sam Wieand;Kathryn Hale;Ming Lee

Frequent Co-Authors

Norman Wolmark
Norman Wolmark University of Pittsburgh
Eleftherios P. Mamounas
Eleftherios P. Mamounas University of Florida Health
Soonmyung Paik
Soonmyung Paik Yonsei University
Sandra M. Swain
Sandra M. Swain Georgetown University Medical Center
Patricia A. Ganz
Patricia A. Ganz University of California, Los Angeles
Louis Fehrenbacher
Louis Fehrenbacher Kaiser Permanente
Bernard Fisher
Bernard Fisher University of Pittsburgh
Charles E. Geyer
Charles E. Geyer University of Pittsburgh
Edwin R. Fisher
Edwin R. Fisher University of Pittsburgh
Adam Brufsky
Adam Brufsky University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring diverse online degrees can open doors to various career paths in the healthcare sector. For those looking to advance quickly, easy dnp programs offer a flexible path to a Doctor of Nursing Practice, designed for working professionals seeking leadership roles.

If you're interested in entering the workforce sooner, consider a fast lpn program, which provides accelerated training for licensed practical nurses. This is ideal for individuals looking for a fast entry into patient care positions without a lengthy degree commitment.

Specializing in mental health is another in-demand area. The shortest post master's pmhnp online programs enable current nurses to efficiently move into psychiatric-mental health nurse practitioner roles.

For those interested in the business side of medicine, an online health care administration degree online prepares students for leadership opportunities in hospital and clinic management, with several affordable options available.

Best Scientists Citing Joseph P. Costantino

Trending Scientists

Recently Published Articles